Literature DB >> 20664908

Phosphate and vascular calcification: Emerging role of the sodium-dependent phosphate co-transporter PiT-1.

Wei Ling Lau1, Maria H Festing, Cecilia M Giachelli.   

Abstract

Elevated serum phosphate is a risk factor for vascular calcification and cardiovascular events in kidney disease as well as in the general population. Elevated phosphate levels drive vascular calcification, in part, by regulating vascular smooth muscle cell (VSMC) gene expression, function, and fate. The type III sodium-dependent phosphate co-transporter, PiT-1, is necessary for phosphate-induced VSMC osteochondrogenic phenotype change and calcification, and has recently been shown to have unexpected functions in cell proliferation and embryonic development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664908      PMCID: PMC3034400          DOI: 10.1160/TH09-12-0814

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  79 in total

1.  High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression.

Authors:  Pablo Román-García; Natalia Carrillo-López; José Luis Fernández-Martín; Manuel Naves-Díaz; María Piedad Ruiz-Torres; Jorge B Cannata-Andía
Journal:  Bone       Date:  2009-09-17       Impact factor: 4.398

2.  Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

Authors:  Rukshana C Shroff; Rosamund McNair; Jeremy N Skepper; Nichola Figg; Leon J Schurgers; John Deanfield; Lesley Rees; Catherine M Shanahan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

3.  Generation of mouse conditional and null alleles of the type III sodium-dependent phosphate cotransporter PiT-1.

Authors:  Maria H Festing; Mei Y Speer; Hsueh-Ying Yang; Cecilia M Giachelli
Journal:  Genesis       Date:  2009-12       Impact factor: 2.487

Review 4.  Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

Authors:  Sankar D Navaneethan; Suetonia C Palmer; Jonathan C Craig; Grahame J Elder; Giovanni F M Strippoli
Journal:  Am J Kidney Dis       Date:  2009-08-18       Impact factor: 8.860

5.  Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.

Authors:  Ada W Y Chung; H H Clarice Yang; Mhairi K Sigrist; Genevieve Brin; Elliott Chum; William A Gourlay; Adeera Levin
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

6.  Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development.

Authors:  Hiroko Segawa; Akemi Onitsuka; Junya Furutani; Ichiro Kaneko; Fumito Aranami; Natsuki Matsumoto; Yuka Tomoe; Masashi Kuwahata; Mikiko Ito; Mitsuru Matsumoto; Minqi Li; Norio Amizuka; Ken-ichi Miyamoto
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-01

Review 7.  Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.

Authors:  Martin K Kuhlmann
Journal:  Blood Purif       Date:  2010-01-08       Impact factor: 2.614

8.  Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi.

Authors:  Ricardo Villa-Bellosta; Moshe Levi; Victor Sorribas
Journal:  Pflugers Arch       Date:  2009-06-09       Impact factor: 3.657

9.  Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells.

Authors:  Nozomu Hosaka; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Fumiko Kondo; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Calcif Tissue Int       Date:  2009-10-06       Impact factor: 4.333

10.  Identification of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity.

Authors:  Laurent Beck; Christine Leroy; Christine Salaün; Germain Margall-Ducos; Chantal Desdouets; Gérard Friedlander
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

View more
  33 in total

Review 1.  Phosphate Toxicity in CKD: The Killer among Us.

Authors:  Cynthia S Ritter; Eduardo Slatopolsky
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-10       Impact factor: 8.237

2.  CKD-mineral and bone disorder: core curriculum 2011.

Authors:  Ranjani N Moorthi; Sharon M Moe
Journal:  Am J Kidney Dis       Date:  2011-10-21       Impact factor: 8.860

Review 3.  Klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

Review 4.  Klotho: a novel regulator of calcium and phosphorus homeostasis.

Authors:  Chou-Long Huang; Orson W Moe
Journal:  Pflugers Arch       Date:  2011-03-29       Impact factor: 3.657

Review 5.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

Review 6.  A current understanding of vascular calcification in CKD.

Authors:  Neil J Paloian; Cecilia M Giachelli
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

7.  Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3-4 chronic kidney disease.

Authors:  Ying Gao; Guiyun Wang; Yang Li; Chenxiao Lv; Zunsong Wang
Journal:  J Nephrol       Date:  2018-12-26       Impact factor: 3.902

8.  Primary familial brain calcification: update on molecular genetics.

Authors:  Ilaria Taglia; Vincenzo Bonifati; Andrea Mignarri; Maria Teresa Dotti; Antonio Federico
Journal:  Neurol Sci       Date:  2015-02-17       Impact factor: 3.307

Review 9.  Biophysical aspects of biomineralization.

Authors:  Maytê Bolean; Ana M S Simão; Marina B Barioni; Bruno Z Favarin; Heitor G Sebinelli; Ekeveliny A Veschi; Tatiane A B Janku; Massimo Bottini; Marc F Hoylaerts; Rosangela Itri; José L Millán; Pietro Ciancaglini
Journal:  Biophys Rev       Date:  2017-08-29

10.  Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients?

Authors:  Merita Rroji; Saimir Seferi; Majlinda Cafka; Elizana Petrela; Erjola Likaj; Myftar Barbullushi; Nestor Thereska; Goce Spasovski
Journal:  Int Urol Nephrol       Date:  2013-04-17       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.